Journal of Applied Physiology AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 86: 1578-1582, 1999;
8750-7587/99 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumgartner, R. W.
Right arrow Articles by Oelz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgartner, R. W.
Right arrow Articles by Oelz, O.
Vol. 86, Issue 5, 1578-1582, May 1999

Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study

Ralf W. Baumgartner1, Ioakim Spyridopoulos2, Peter Bärtsch3, Marco Maggiorini4, and Oswald Oelz4

Departments of 1 Neurology and 4 Internal Medicine, University Hospital, CH-8091 Zürich, Switzerland; 2 Department of Internal Medicine III, Eberhard-Karls-University, 72070 Tübingen; and 3 Department of Internal Medicine, Division of Sports Medicine, University of Heidelberg, 69115 Heidelberg, Germany

To evaluate the pathogenetic role of cerebral blood flow (CBF) changes occurring before and during the development of acute mountain sickness (AMS), peak mean middle cerebral artery flow velocities (<OVL><IT>V</IT></OVL><SUB>MCA</SUB>) were assessed by transcranial Doppler sonography in 10 subjects at 490-m altitude, and during three 12-min periods immediately (SA1), 3 (SA2), and 6 (SA3) h after decompression to a simulated altitude of 4,559 m. AMS cerebral scores increased from 0.16 ± 0.14 at baseline to 0.44 ± 0.31 at SA1, 1.11 ± 0.88 at SA2 (P < 0.05), and 1.43 ± 1.03 at SA3 (P < 0.01); correspondingly, three, seven, and eight subjects had AMS. Absolute and relative <OVL><IT>V</IT></OVL><SUB>MCA</SUB> at simulated altitude, expressed as percentages of low-altitude values (%<OVL><IT>V</IT></OVL><SUB>MCA</SUB>), did not correlate with AMS cerebral scores. Average %<OVL><IT>V</IT></OVL><SUB>MCA</SUB> remained unchanged, because %<OVL><IT>V</IT></OVL><SUB>MCA</SUB> increased in three and remained unchanged or decreased in seven subjects at SA2 and SA3. These results suggest that CBF is not important in the pathogenesis of AMS and shows substantial interindividual differences during the first hours at simulated altitude.

altitude illness; cerebral hemodynamics; ultrasonics


This article has been cited by other articles:


Home page
StrokeHome page
A. Van Osta, J.-J. Moraine, C. Melot, H. Mairbaurl, M. Maggiorini, and R. Naeije
Effects of High Altitude Exposure on Cerebral Hemodynamics in Normal Subjects
Stroke, March 1, 2005; 36(3): 557 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
R. C. Roach and P. H. Hackett
Frontiers of hypoxia research: acute mountain sickness
J. Exp. Biol., March 11, 2002; 204(18): 3161 - 3170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online